Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D.A. Kesper, O. Pinkenburg, P.I. Pfefferle, H. Garn, H. Renz (Marburg, Germany). Analysis of IL-6 function in transmaternal asthma protection induced by Acinetobacter Iwoffii. Eur Respir J 2012; 40: Suppl. 56, 231

Member's Comments

No comment yet.

Related content which might interest you: Interleukin-6 is important for the development of Acinetobacter lwoffii-mediated protection against asthma Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Acinetobacter lwoffii and lactococcus lactis strains isolated from cowsheds of traditional farms suppress allergic airway inflammation in a mouse model of experimental asthma Source: Eur Respir J 2007; 30: Suppl. 51, 736s Year: 2007 Therapeutic intratracheal phage application against Acinetobacter baumannii lung infection in mice Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 IL-10 induced T-cell tolerance to Aspergillus fumigatus and Pseudomonas aeruginosa in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001 Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections Year: 2008 Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin Source: Eur Respir J 2004; 24: Suppl. 48, 107s Year: 2004 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response Source: Eur Respir J 2007; 30: 1167-1172 Year: 2007 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Clinical  profile  and outcome of patients with sputum positive Acinetobacter baumanni infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Novel swine ARDS model induced by Pseudomonas aeruginosa pneumonia and VILI Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Acinetobacter baumanii as a severity marker in a respiratory ICU Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 IL-6 and IL-8 production induced by Pseudomonas aeruginosa flagellin in human bronchial epithelial cells. Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Azithromycin protects bronchial epithelial integrity after Pseudomonas aeruginosa infection independent of bactericidal activity Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018